Dendritic cell, the immunotherapeutic cell for cancer.
Article
in English
| IMSEAR
| ID: sea-21204
ABSTRACT
Dendritic cells play an important role in the development of effective cancer vaccines. These cells have the potential to present tumour-specific antigens and thereby induce an immune response. Various studies involving clinical trials have investigated the efficacy of administering antigen-loaded dendritic cells for cancer therapy. In order to design such experiments it is important to consider specific antigens, which initiate either a CD4+ or CD8+ response or both. The present review discusses the unique properties of dendritic cells as an immunotherapeutic cell for cancer.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Peptides
/
Dendritic Cells
/
Humans
/
Vaccines
/
Transfection
/
CD4-Positive T-Lymphocytes
/
Clinical Trials as Topic
/
CD8-Positive T-Lymphocytes
/
Immunotherapy
/
Antigens, Neoplasm
Language:
English
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS